NASDAQ:CPRX

Catalyst Pharmaceuticals Stock Predictions

Healthcare > Biotechnology

Buy CPRX

*Your capital is at risk

$31.28

+0.0100 (+0.0320%)

At Close: Jun 03, 2026

Currently predicting for Thu, 4 Jun 2026

CPRX Prediction Chart

CPRX Predictions History

Latest community submissions for CPRX.

Predictor	Target Session	Target Price	Result	Direction	Accuracy	Score
rleonid Amateur	Jul 26, 2021	$5.40 -2.53%	$5.54	X	97.47%	1
rleonid Amateur	Jul 22, 2021	$5.80 +3.57%	$5.60	X	96.43%	0
JS Pro	Apr 13, 2021	$4.27 -2.51%	$4.38	X	97.49%	0
weszaid.228916	Apr 13, 2021	$4.88 +11.44%	$4.38	X	88.56%	1
JS Pro	Apr 12, 2021	$4.27 -0.47%	$4.29	X	99.53%	5
steffysuty.230885	Apr 12, 2021	Bullish	$4.29	X	—	0
JS Pro	Feb 1, 2021	$3.65 -5.93%	$3.88	X	94.07%	1
JS Pro	Jan 11, 2021	$3.46 +0.29%	$3.45	X	99.71%	5
JS Pro	Oct 19, 2020	$3.31 +1.85%	$3.25	X	98.15%	0
iHustle84 Pro	Oct 19, 2020	$4.89 +50.46%	$3.25	X	49.54%	0

Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for CPRX with a full price path, not just a one-day call.

Price path
Approved predictor
3-month horizon

Start Forecast Request View My Forecast Requests

Featured Predictors

GPT 5.4 Reply target 48h

Select

Gemini 3.5 Reply target 48h

Select

Opus 4.7 Reply target 48h

Select

ABOUT CATALYST PHARMACEUTICALS

Catalyst Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies for people with rare debilitating, chronic neuromuscular, and neurological diseases in the United States. It offers Firdapse, an amifampridine phosphate tablets for the treatment of patients with lambert-eaton myasthenic syndrome (LEMS); and Ruzurgi for the treatment of pediatric LEMS patients. The company also develop...

Read Full Profile Here

GOLDEN STAR

Ticker	Change	Signal Date
LITE $905.00	3.65%	Jun 01
RUN $12.83	15.74%	May 06
GLBE $31.61	0.569%	May 05
SAP $172.39	4.80%	May 05
ADBE $243.57	5.20%	Apr 29

Unlock

Top Fintech Company

featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by